NVOX has announced the launch of the NVOX Network, its US clinical network, and is inviting psychologists, psychiatrists, and other qualified clinical professionals to join. The company says the platform is designed to reduce the operational burden surrounding comprehensive ADHD assessment while keeping clinical interpretation in professional hands.
The US launch follows more than three and a half years of development, and more than 1,000 completed assessments during NVOX’s initial opening phase. NVOX previewed the platform with clinicians and other professionals at APA 2026 in Washington D.C., gathering feedback ahead of the NVOX Network rollout.
A 2026 study lead by CDC researchers and published in the Journal of the American Board of Family Medicine found that fewer than half of surveyed clinicians reported offering ADHD diagnostic services in their practices, 46% for adults and 42.6% for children.
Among clinicians involved in ADHD care, lack of time to evaluate the patient was the most frequently reported barrier to ADHD identification or diagnosis, cited by roughly four in ten clinicians for both adults and children.
“Responsible ADHD assessment requires much more than identifying symptoms,” said Johnathan Leemor, M.D., chief science officer at NVOX. “It requires developmental history, functioning, context, information from multiple sources and careful clinical interpretation.
“NVOX was designed to organise that complexity so clinicians can spend more time understanding the person and applying clinical judgment, and less time assembling the process. Reducing that burden can help expand clinical capacity and access. Professional ADHD assessment should not be a luxury product.”
